| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA2D1 SLC25A42 SLC25A20 ATP5PO SLCO2B1 PIEZO1 SLCO4A1 SLCO3A1 MCL1 CATSPER3 SLC1A1 CLDN2 ABCG1 ABCB9 CLCN7 SLC16A1 SV2A SLC22A3 SLC17A8 OTOP1 MFSD8 OSCP1 CNGB1 SLC23A1 SLC25A17 ATP6V0A2 | 2.65e-07 | 1180 | 143 | 26 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CACNA2D1 SLC25A42 SLC25A20 ATP5PO SLCO2B1 PIEZO1 SLCO4A1 SLCO3A1 MCL1 CATSPER3 SLC1A1 CLDN2 ABCG1 ABCB9 CLCN7 SLC16A1 SV2A SLC22A3 SLC17A8 OTOP1 SCP2 MFSD8 OSCP1 CNGB1 SLC23A1 SLC25A17 ATP6V0A2 | 4.09e-07 | 1289 | 143 | 27 | GO:0005215 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC25A42 SLCO2B1 SLCO4A1 SLCO3A1 SLC1A1 ABCG1 ABCB9 CLCN7 SLC16A1 SLC22A3 SLC17A8 SLC23A1 SLC25A17 ATP6V0A2 | 8.71e-06 | 477 | 143 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC25A42 SLCO2B1 SLCO4A1 SLCO3A1 SLC1A1 CLCN7 SLC16A1 SLC22A3 SLC17A8 SLC23A1 SLC25A17 | 9.63e-06 | 296 | 143 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | protein phosphatase binding | 2.09e-05 | 210 | 143 | 9 | GO:0019903 | |
| GeneOntologyMolecularFunction | phosphatase binding | 2.10e-05 | 264 | 143 | 10 | GO:0019902 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TNIK TNK1 MINK1 LRRK2 DGKB DGKG MAGI3 GCK MET PARP1 IKBKE CSNK1D CSNK1E POLR1B ROS1 POLQ GMPPB TSSK1B MAP2K7 | 4.13e-05 | 938 | 143 | 19 | GO:0016772 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC25A42 SLCO2B1 SLCO4A1 SLCO3A1 SLC1A1 SLC16A1 SLC22A3 SLC17A8 SLC23A1 SLC25A17 | 5.09e-05 | 293 | 143 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | AMP transmembrane transporter activity | 5.09e-05 | 2 | 143 | 2 | GO:0080122 | |
| GeneOntologyMolecularFunction | G protein activity | 6.44e-05 | 59 | 143 | 5 | GO:0003925 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 1.24e-04 | 14 | 143 | 3 | GO:0015132 | |
| GeneOntologyMolecularFunction | coenzyme A transmembrane transporter activity | 1.52e-04 | 3 | 143 | 2 | GO:0015228 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 1.54e-04 | 15 | 143 | 3 | GO:0071714 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 2.71e-04 | 18 | 143 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 3.26e-04 | 83 | 143 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | kinase activity | TNIK TNK1 MINK1 LRRK2 DGKB DGKG MAGI3 GCK MET IKBKE CSNK1D CSNK1E ROS1 TSSK1B MAP2K7 | 3.90e-04 | 764 | 143 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | channel activity | CACNA2D1 ATP5PO PIEZO1 MCL1 CATSPER3 SLC1A1 CLDN2 CLCN7 SLC17A8 OTOP1 MFSD8 CNGB1 | 4.04e-04 | 525 | 143 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA2D1 ATP5PO PIEZO1 MCL1 CATSPER3 SLC1A1 CLDN2 CLCN7 SLC17A8 OTOP1 MFSD8 CNGB1 | 4.11e-04 | 526 | 143 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 5.02e-04 | 5 | 143 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 5.02e-04 | 5 | 143 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TNIK TNK1 MINK1 LRRK2 DGKB DGKG GCK MET IKBKE CSNK1D CSNK1E ROS1 TSSK1B MAP2K7 | 5.80e-04 | 709 | 143 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | adenosine 3',5'-bisphosphate transmembrane transporter activity | 7.50e-04 | 6 | 143 | 2 | GO:0071077 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.60e-03 | 70 | 143 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.67e-03 | 119 | 143 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA2D1 ATP5PO PIEZO1 CATSPER3 SLC1A1 CLCN7 SLC16A1 SLC22A3 SLC17A8 OTOP1 MFSD8 CNGB1 SLC23A1 ATP6V0A2 | 1.69e-03 | 793 | 143 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA2D1 ATP5PO PIEZO1 CATSPER3 SLC1A1 CLCN7 SLC17A8 OTOP1 MFSD8 CNGB1 | 1.76e-03 | 459 | 143 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.87e-03 | 73 | 143 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.07e-03 | 125 | 143 | 5 | GO:0015108 | |
| GeneOntologyBiologicalProcess | organic cation transport | SLC25A42 SLC25A20 GCK SLC1A1 SLC22A3 SLC17A8 SLC25A17 SEC14L1 | 6.72e-06 | 145 | 140 | 8 | GO:0015695 |
| GeneOntologyBiologicalProcess | neurotransmitter transport | RAP1A RAP1B LRRK2 SLC1A1 NRXN3 NRXN2 SV2A SLC22A3 SLC17A8 BAIAP3 | 1.12e-05 | 259 | 140 | 10 | GO:0006836 |
| GeneOntologyBiologicalProcess | microvillus assembly | 3.67e-05 | 28 | 140 | 4 | GO:0030033 | |
| GeneOntologyBiologicalProcess | AMP transport | 4.57e-05 | 2 | 140 | 2 | GO:0080121 | |
| GeneOntologyBiologicalProcess | protein autoprocessing | 4.86e-05 | 30 | 140 | 4 | GO:0016540 | |
| GeneOntologyBiologicalProcess | cellular response to nerve growth factor stimulus | 5.00e-05 | 59 | 140 | 5 | GO:1990090 | |
| GeneOntologyBiologicalProcess | response to nerve growth factor | 5.88e-05 | 61 | 140 | 5 | GO:1990089 | |
| GeneOntologyBiologicalProcess | microvillus organization | 8.05e-05 | 34 | 140 | 4 | GO:0032528 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC25A20 SLCO2B1 SLCO4A1 SLCO3A1 SLC1A1 SLC16A1 SV2A SLC22A3 SLC17A8 SLC23A1 SLC25A17 | 1.15e-04 | 410 | 140 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC25A20 SLCO2B1 SLCO4A1 SLCO3A1 SLC1A1 SLC16A1 SV2A SLC22A3 SLC17A8 SLC23A1 SLC25A17 | 1.20e-04 | 412 | 140 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | sodium-independent organic anion transport | 1.31e-04 | 15 | 140 | 3 | GO:0043252 | |
| GeneOntologyBiologicalProcess | coenzyme A transmembrane transport | 1.37e-04 | 3 | 140 | 2 | GO:0035349 | |
| GeneOntologyBiologicalProcess | coenzyme A transport | 1.37e-04 | 3 | 140 | 2 | GO:0015880 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC25A42 SLC25A20 SLCO2B1 SLCO4A1 SLCO3A1 SLC1A1 SLC16A1 SV2A SLC22A3 SLC17A8 SLC23A1 SLC25A17 | 2.09e-04 | 515 | 140 | 12 | GO:0015711 |
| GeneOntologyBiologicalProcess | peptide metabolic process | 2.69e-04 | 84 | 140 | 5 | GO:0006518 | |
| GeneOntologyBiologicalProcess | adenosine 3',5'-bisphosphate transmembrane transport | 2.72e-04 | 4 | 140 | 2 | GO:0071106 | |
| Domain | MFS_dom | 9.45e-06 | 134 | 144 | 8 | IPR020846 | |
| Domain | - | 5.41e-05 | 53 | 144 | 5 | 1.50.40.10 | |
| Domain | Mito_carr | 5.41e-05 | 53 | 144 | 5 | PF00153 | |
| Domain | SOLCAR | 5.41e-05 | 53 | 144 | 5 | PS50920 | |
| Domain | Mitochondrial_sb/sol_carrier | 5.41e-05 | 53 | 144 | 5 | IPR018108 | |
| Domain | Mt_carrier_dom | 5.41e-05 | 53 | 144 | 5 | IPR023395 | |
| Domain | OA_transporter | 9.38e-05 | 12 | 144 | 3 | IPR004156 | |
| Domain | OATP | 9.38e-05 | 12 | 144 | 3 | PF03137 | |
| Domain | - | 1.76e-04 | 3 | 144 | 2 | 1.10.238.110 | |
| Domain | DAG_kinase_N | 1.76e-04 | 3 | 144 | 2 | PF14513 | |
| Domain | DAG_kinase_typeI_N | 1.76e-04 | 3 | 144 | 2 | IPR029477 | |
| Domain | MFS | 1.90e-04 | 108 | 144 | 6 | PS50850 | |
| Domain | MFS_1 | 3.21e-04 | 77 | 144 | 5 | PF07690 | |
| Domain | MFS | 3.21e-04 | 77 | 144 | 5 | IPR011701 | |
| Pathway | REACTOME_MET_ACTIVATES_RAP1_AND_RAC1 | 8.11e-05 | 11 | 114 | 3 | M27776 | |
| Pathway | REACTOME_MET_ACTIVATES_RAP1_AND_RAC1 | 8.11e-05 | 11 | 114 | 3 | MM15515 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 8.11e-05 | 11 | 114 | 3 | M930 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 1.07e-04 | 12 | 114 | 3 | MM15476 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RAP1A RAP1B ATP5PO APMAP PSMB3 ABHD3 NASP MCL1 ABCF2 PARP1 SLC16A1 PA2G4 CSNK1D AASS CSNK1E POLR1B CDC5L CDC27 GMPPB MAP2K7 | 3.00e-07 | 1257 | 145 | 20 | 37317656 |
| Pubmed | Rap2A links intestinal cell polarity to brush border formation. | 3.82e-07 | 15 | 145 | 4 | 22797597 | |
| Pubmed | 6.55e-07 | 304 | 145 | 10 | 32235678 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 10873595 | ||
| Pubmed | 1.41e-06 | 6 | 145 | 3 | 23230271 | ||
| Pubmed | 1.41e-06 | 6 | 145 | 3 | 30683685 | ||
| Pubmed | The mitochondrial transporter family SLC25: identification, properties and physiopathology. | 2.87e-06 | 53 | 145 | 5 | 23266187 | |
| Pubmed | Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. | 3.91e-06 | 8 | 145 | 3 | 19129463 | |
| Pubmed | Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis. | 3.91e-06 | 8 | 145 | 3 | 29588315 | |
| Pubmed | 5.85e-06 | 9 | 145 | 3 | 37267105 | ||
| Pubmed | Localization of the 5' end of the MCF2 oncogene to human chromosome 15q15----q23. | 5.85e-06 | 9 | 145 | 3 | 1611909 | |
| Pubmed | 8.34e-06 | 10 | 145 | 3 | 25500533 | ||
| Pubmed | 1.14e-05 | 11 | 145 | 3 | 14579113 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 13679863 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 25807985 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 12628722 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 24424021 | ||
| Pubmed | Rap1 Is Essential for B-Cell Locomotion, Germinal Center Formation and Normal B-1a Cell Population. | 1.73e-05 | 2 | 145 | 2 | 34140948 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 29222111 | ||
| Pubmed | Effect of DNA methylation profile on OATP3A1 and OATP4A1 transcript levels in colorectal cancer. | 1.73e-05 | 2 | 145 | 2 | 26349991 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 9632646 | ||
| Pubmed | Enhanced cortico-amygdala efficacy and suppressed fear in absence of Rap1. | 1.73e-05 | 2 | 145 | 2 | 18305243 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 11258948 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 31601924 | ||
| Pubmed | Mutation in RAP1 is a rare event in myelodysplastic syndromes. | 1.73e-05 | 2 | 145 | 2 | 16118622 | |
| Pubmed | Mutation analysis of RAP1 gene in papillary thyroid carcinomas. | 1.73e-05 | 2 | 145 | 2 | 18948674 | |
| Pubmed | Expression of Rap 1 suppresses genomic instability of H-ras transformed mouse fibroblasts. | 1.73e-05 | 2 | 145 | 2 | 9330640 | |
| Pubmed | Rap1 GTPase activation and barrier enhancement in rpe inhibits choroidal neovascularization in vivo. | 1.73e-05 | 2 | 145 | 2 | 24039860 | |
| Pubmed | Gut-derived GIP activates central Rap1 to impair neural leptin sensitivity during overnutrition. | 1.73e-05 | 2 | 145 | 2 | 31403469 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 35008476 | ||
| Pubmed | Galpha and Gbeta gamma require distinct Src-dependent pathways to activate Rap1 and Ras. | 1.73e-05 | 2 | 145 | 2 | 12221082 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 18805968 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 18191594 | ||
| Pubmed | Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial. | 1.73e-05 | 2 | 145 | 2 | 31584608 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 2108841 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 18056377 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 34128835 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 18625726 | ||
| Pubmed | Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing. | 1.73e-05 | 2 | 145 | 2 | 34059671 | |
| Pubmed | Piezo1 specific deletion in macrophage protects the progression of liver fibrosis in mice. | 1.73e-05 | 2 | 145 | 2 | 37908726 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 19043076 | ||
| Pubmed | Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity. | 1.73e-05 | 2 | 145 | 2 | 31435009 | |
| Pubmed | Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining. | 1.73e-05 | 2 | 145 | 2 | 33911081 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 3141412 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 38474193 | ||
| Pubmed | ABCG1 regulates pulmonary surfactant metabolism in mice and men. | 1.73e-05 | 2 | 145 | 2 | 28264879 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 25404202 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 37089864 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 30674576 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 32651478 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 31361233 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 26804993 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 32184389 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 21220347 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 22981886 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 12399522 | ||
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 24836575 | ||
| Pubmed | Telomere-dependent and telomere-independent roles of RAP1 in regulating human stem cell homeostasis. | 1.73e-05 | 2 | 145 | 2 | 30796637 | |
| Pubmed | 1.73e-05 | 2 | 145 | 2 | 23946483 | ||
| Pubmed | 1.97e-05 | 13 | 145 | 3 | 16949250 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EPPK1 NCKAP1 PSMB3 NASP DGKB NDN PSTPIP1 QRICH2 MET SLC16A1 IKBKE PA2G4 CSNK1D CSNK1E CDC5L POLQ LYZ | 2.71e-05 | 1284 | 145 | 17 | 17353931 |
| Pubmed | CACNA2D1 AMPH ATP5PO NCKAP1 MINK1 PSMB3 NARS1 DGKB HDHD2 PARP1 NRXN2 SV2A CSNK1D KNDC1 CDC5L LYZ RASAL1 PPP1R12C | 3.03e-05 | 1431 | 145 | 18 | 37142655 | |
| Pubmed | RAP1A RAP1B ATP5PO SLCO2B1 DNAH2 MAGI3 ABCF2 PARP1 NRXN3 ABCB9 CEBPZ SEC23IP CC2D2A PABPC1L POLQ CDC27 RAC3 MYBPC1 | 3.35e-05 | 1442 | 145 | 18 | 35575683 | |
| Pubmed | 3.82e-05 | 16 | 145 | 3 | 21945075 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 24642466 | ||
| Pubmed | Rap1 signaling prevents L-type calcium channel-dependent neurotransmitter release. | 5.16e-05 | 3 | 145 | 2 | 23616533 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 38891114 | ||
| Pubmed | Differential regulation of breast cancer bone metastasis by PARP1 and PARP2. | 5.16e-05 | 3 | 145 | 2 | 32221289 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 33571427 | ||
| Pubmed | Rap1 small GTPase is essential for maintaining pulmonary endothelial barrier function in mice. | 5.16e-05 | 3 | 145 | 2 | 38010922 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 12270714 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 32539601 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 27010854 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 33402590 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 16406382 | ||
| Pubmed | Rap1 and its effector RIAM are required for lymphocyte trafficking. | 5.16e-05 | 3 | 145 | 2 | 26324702 | |
| Pubmed | Analysis of the status of EGFR, ROS1 and MET genes in non-small cell lung adenocarcinoma. | 5.16e-05 | 3 | 145 | 2 | 28952227 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 31005376 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 25724478 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 22577140 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 25665722 | ||
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 32321936 | ||
| Pubmed | Alveolar Macrophage ABCG1 Deficiency Promotes Pulmonary Granulomatous Inflammation. | 5.16e-05 | 3 | 145 | 2 | 30848658 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 36696631 | ||
| Pubmed | Casein kinase 1-epsilon or 1-delta required for Wnt-mediated intestinal stem cell maintenance. | 5.16e-05 | 3 | 145 | 2 | 28963394 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 31353086 | ||
| Pubmed | Mcl-1 suppresses abasic site repair following bile acid-induced hepatic cellular DNA damage. | 5.16e-05 | 3 | 145 | 2 | 28681695 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 8786104 | ||
| Pubmed | Differences in the Phosphorylation-Dependent Regulation of Prenylation of Rap1A and Rap1B. | 5.16e-05 | 3 | 145 | 2 | 27760305 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 30464050 | ||
| Pubmed | Epsin Nanotherapy Regulates Cholesterol Transport to Fortify Atheroma Regression. | 5.16e-05 | 3 | 145 | 2 | 36444722 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 5.16e-05 | 3 | 145 | 2 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 5.16e-05 | 3 | 145 | 2 | 11944992 | |
| Pubmed | Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes. | 5.16e-05 | 3 | 145 | 2 | 20733035 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 5.16e-05 | 3 | 145 | 2 | 17035546 | |
| Pubmed | 5.16e-05 | 3 | 145 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 5.16e-05 | 3 | 145 | 2 | 25423136 | |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 5.16e-05 | 3 | 145 | 2 | 34133920 | |
| Pubmed | RNA Sensing by Gut Piezo1 Is Essential for Systemic Serotonin Synthesis. | 5.16e-05 | 3 | 145 | 2 | 32640190 | |
| GeneFamily | Solute carriers | SLC25A42 SLC25A20 SLCO2B1 SLC25A34 SLCO4A1 SLCO3A1 SLC1A1 SLC25A35 SLC16A1 SLC22A3 SLC17A8 SLC23A1 SLC25A17 | 2.40e-07 | 395 | 99 | 13 | 752 |
| GeneFamily | RAS type GTPase family | 6.40e-04 | 31 | 99 | 3 | 389 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 8.13e-04 | 8 | 99 | 2 | 658 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 1.04e-03 | 9 | 99 | 2 | 973 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 1.30e-03 | 10 | 99 | 2 | 1178 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 3.42e-08 | 150 | 145 | 8 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 176 | 145 | 8 | 8e89471f838ea81235256cc2470f1c12c9b75f8a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.73e-07 | 185 | 145 | 8 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.80e-07 | 186 | 145 | 8 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7-Slc17a6.Nptxr-Rorb_(Deep_layer_pyramidal_cells--Layer_5a)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.81e-07 | 125 | 145 | 7 | be820e4db3da737101f34ea9d2848a3ceb53f417 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.96e-07 | 188 | 145 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.96e-07 | 188 | 145 | 8 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.30e-07 | 192 | 145 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | IPF-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 2.30e-07 | 192 | 145 | 8 | 356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-07 | 193 | 145 | 8 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.90e-07 | 198 | 145 | 8 | 1fe51f4beca0eef4ff117e6edaa646e35c0f9629 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.73e-07 | 139 | 145 | 7 | 2fb51abb3ce88c21726c026d6365b2582e2e79f6 | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-07 | 157 | 145 | 7 | 9d4308312301cb922f156a7b6aededc9e1c62807 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.25e-07 | 159 | 145 | 7 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-06 | 169 | 145 | 7 | 813472d429c0b12580b17b440e00a6d8beb7947f | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 172 | 145 | 7 | 574ebdf36e45222bcd907cd2c2ee7ff50ed4573a | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 172 | 145 | 7 | 1627fa7035b0e0bbc82a1c0f000d8231254c680a | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.12e-06 | 180 | 145 | 7 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.20e-06 | 181 | 145 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.36e-06 | 183 | 145 | 7 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.54e-06 | 185 | 145 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.63e-06 | 186 | 145 | 7 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 2.73e-06 | 187 | 145 | 7 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.82e-06 | 188 | 145 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-06 | 189 | 145 | 7 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 2.92e-06 | 189 | 145 | 7 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-06 | 189 | 145 | 7 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.03e-06 | 190 | 145 | 7 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-06 | 190 | 145 | 7 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 3.13e-06 | 191 | 145 | 7 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.13e-06 | 191 | 145 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 3.13e-06 | 191 | 145 | 7 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.13e-06 | 191 | 145 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.13e-06 | 191 | 145 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 3.24e-06 | 192 | 145 | 7 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 3.24e-06 | 192 | 145 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.36e-06 | 193 | 145 | 7 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|Myeloid / Disease state, Lineage and Cell class | 3.36e-06 | 193 | 145 | 7 | 80871d963c23a6befe58e5e60b7f7d1a1b227ce2 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 3.36e-06 | 193 | 145 | 7 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.36e-06 | 193 | 145 | 7 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-06 | 195 | 145 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.97e-06 | 198 | 145 | 7 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.11e-06 | 199 | 145 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Transitional_AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.11e-06 | 199 | 145 | 7 | e04a57a55c724091db353e2b3baf84372d788728 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 199 | 145 | 7 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Transitional_AT2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.25e-06 | 200 | 145 | 7 | dfa897ef5ce4744c77b6e5ee5a0d6d83229d1691 | |
| ToppCell | Biopsy_IPF-Epithelial-SCGB3A2+|Biopsy_IPF / Sample group, Lineage and Cell type | 4.25e-06 | 200 | 145 | 7 | 2aaf130d702d18c277d16b6800f006a53ed653fb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Transitional_AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.25e-06 | 200 | 145 | 7 | 8d1c78dd829cbc290820d5118f24ff7f828a8622 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Transitional_AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.25e-06 | 200 | 145 | 7 | 992bd6b1feac2afded6eb927ac95ddf5cfef961c | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.23e-05 | 156 | 145 | 6 | 166f7b1220eaf8e1149dde260dd85a094855c54f | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.23e-05 | 156 | 145 | 6 | 5e1c5a7c9293b886920739cf766521df7f69726c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.28e-05 | 157 | 145 | 6 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.37e-05 | 159 | 145 | 6 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.53e-05 | 162 | 145 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 1.58e-05 | 163 | 145 | 6 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 164 | 145 | 6 | 85f53d184fa70e3eb1af655807f32b17ddbfb304 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 164 | 145 | 6 | 144ba070a1ede71684224cc6d4ead3b7e6a7b4c6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.75e-05 | 166 | 145 | 6 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 168 | 145 | 6 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-05 | 177 | 145 | 6 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | COPD-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 2.68e-05 | 179 | 145 | 6 | 988d0853c391da1e5004f73f3678047418d3f6d3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.68e-05 | 179 | 145 | 6 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 2.77e-05 | 180 | 145 | 6 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.85e-05 | 181 | 145 | 6 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.94e-05 | 182 | 145 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 3.13e-05 | 184 | 145 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4|TCGA-Uvea / Sample_Type by Project: Shred V9 | 3.13e-05 | 184 | 145 | 6 | 9c56753e5e668be888662e4713cf4ce44e6c58fb | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.13e-05 | 184 | 145 | 6 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 3.23e-05 | 185 | 145 | 6 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | MS-matDC|MS / Condition, Cell_class and T cell subcluster | 3.23e-05 | 185 | 145 | 6 | 46bd897349598d85e718e25f9a045d2247723c61 | |
| ToppCell | MS-matDC-|MS / Condition, Cell_class and T cell subcluster | 3.23e-05 | 185 | 145 | 6 | 9fbe70d3a7b106fb31e13b7f95029785f28ca6f4 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.33e-05 | 186 | 145 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 3.33e-05 | 186 | 145 | 6 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.43e-05 | 187 | 145 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class | 3.43e-05 | 187 | 145 | 6 | 19d6a404fc3651d98a93e3848e372df51a239c57 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.43e-05 | 187 | 145 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.53e-05 | 188 | 145 | 6 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-05 | 188 | 145 | 6 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-05 | 189 | 145 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.64e-05 | 189 | 145 | 6 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|COPD / Disease state, Lineage and Cell class | 3.75e-05 | 190 | 145 | 6 | 006e31606d637033bc81333816ee332773d36b08 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.86e-05 | 191 | 145 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 3.86e-05 | 191 | 145 | 6 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 3.86e-05 | 191 | 145 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-05 | 192 | 145 | 6 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 3.97e-05 | 192 | 145 | 6 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 3.97e-05 | 192 | 145 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 3.97e-05 | 192 | 145 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 192 | 145 | 6 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.09e-05 | 193 | 145 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.09e-05 | 193 | 145 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-05 | 194 | 145 | 6 | 5b29c843186c2394f5bec3b1d5ae284a0d931d85 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-05 | 194 | 145 | 6 | ebcf6c6d0eb20a5d422becf5a730089230c8ba9a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-05 | 194 | 145 | 6 | 8c6e5ba27a988e0cd6b8c25cb9a30a0da2b1f7f9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.21e-05 | 194 | 145 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-05 | 194 | 145 | 6 | 6e78e3046c5b172af92a84e25f982377a0aaac58 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.33e-05 | 195 | 145 | 6 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.33e-05 | 195 | 145 | 6 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.33e-05 | 195 | 145 | 6 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-05 | 195 | 145 | 6 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| Drug | probenecid | 1.18e-06 | 123 | 144 | 8 | CID000004911 | |
| Drug | NDSB195 | 4.89e-06 | 6 | 144 | 3 | CID000448830 | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A | 5.11e-06 | 199 | 144 | 9 | 4995_UP | |
| Disease | Kabuki make-up syndrome | 1.29e-04 | 4 | 138 | 2 | C0796004 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 3.01e-04 | 28 | 138 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 4.49e-04 | 7 | 138 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | white matter hyperintensity measurement | 5.68e-04 | 302 | 138 | 7 | EFO_0005665 | |
| Disease | Familial hyperinsulinism | 5.97e-04 | 8 | 138 | 2 | cv:C3888018 | |
| Disease | Autism Spectrum Disorders | 6.92e-04 | 85 | 138 | 4 | C1510586 | |
| Disease | initial pursuit acceleration | 7.55e-04 | 87 | 138 | 4 | EFO_0008434 | |
| Disease | underweight body mass index status | 7.65e-04 | 9 | 138 | 2 | EFO_0005936 | |
| Disease | Weight Gain | 1.37e-03 | 102 | 138 | 4 | C0043094 | |
| Disease | cathepsin L1 measurement | 2.50e-03 | 16 | 138 | 2 | EFO_0010619 | |
| Disease | erythritol measurement | 2.82e-03 | 17 | 138 | 2 | EFO_0021171 | |
| Disease | hyperglycemia (implicated_via_orthology) | 2.82e-03 | 17 | 138 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | hypertension, white matter hyperintensity measurement | 3.09e-03 | 62 | 138 | 3 | EFO_0000537, EFO_0005665 | |
| Disease | bitter alcoholic beverage consumption measurement | 3.58e-03 | 133 | 138 | 4 | EFO_0010092 | |
| Disease | telomere length | 3.63e-03 | 313 | 138 | 6 | EFO_0004505 | |
| Disease | obstructive sleep apnea | 3.69e-03 | 66 | 138 | 3 | EFO_0003918 | |
| Disease | forced expiratory volume | 4.06e-03 | 789 | 138 | 10 | EFO_0004314 | |
| Disease | myeloid white cell count | RAP1A PIEZO1 DGKG PSTPIP1 ITGAL GGT5 KLHL29 MET POLR1B OSCP1 LYZ | 4.64e-03 | 937 | 138 | 11 | EFO_0007988 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MRKIIGRYGLTGKQQ | 496 | Q9UG63 | |
| GLRGTMQLKNISYGI | 81 | Q6NVV9 | |
| LGGYQSRAMGLMKQL | 721 | Q99459 | |
| DGMQSLRILKLIGYS | 146 | Q86XQ3 | |
| GAGKSTLMNILAGYR | 121 | P45844 | |
| LAGYRETGMKGAVLI | 131 | P45844 | |
| EVIGLKGMGRYFKQI | 311 | O94812 | |
| LGIYKSDLDRIGGMN | 931 | Q6L9W6 | |
| SMGTRRKVLVLGSGY | 476 | Q9UDR5 | |
| MGGMLLLNYLGKIGS | 221 | Q8WU67 | |
| IRRVYVSGLMKGGAD | 281 | Q9HDC9 | |
| RKRIGQGMLSIGYAV | 421 | A6NHC0 | |
| SGQIEVVKYLLRMGA | 216 | Q8NB46 | |
| ILGGMIVRIGEKYVD | 181 | P48047 | |
| LQRELRGYLAAIKGM | 56 | P49418 | |
| QMRETSLGLLTGYLG | 406 | O95294 | |
| MREYKLVVLGSGGVG | 1 | P62834 | |
| MREYKLVVLGSGGVG | 1 | P61224 | |
| QGLAMAREIGSVKYL | 141 | P60763 | |
| LGLDGHIYKGRMDTR | 1596 | Q9H0J4 | |
| MLRGVLGKTFRLVGY | 1 | Q96LU5 | |
| IGLILLGEVALGNMY | 916 | P09874 | |
| KLIGGKYMGELVRLV | 291 | P35557 | |
| NKYYMLVARGLLGIG | 131 | Q8NHS3 | |
| KIFPMGDRLYIGLAG | 41 | P49720 | |
| MLYLIGLGLGDAKDI | 1 | Q9H2P9 | |
| YKMGGDIANRVLRSL | 21 | Q9UQ80 | |
| NKYGSRIVMIVGGCL | 81 | P53985 | |
| GYEVLLQRLLDGRKM | 21 | O43586 | |
| LARTLKRLGMDGYRG | 26 | P61626 | |
| KRLGMDGYRGISLAN | 31 | P61626 | |
| RGGKEYNMGLFILRL | 1036 | Q5TCQ9 | |
| VGMLGILVKTGKYRA | 216 | Q9H0R4 | |
| MKALILVGGYGTRLR | 1 | Q9Y5P6 | |
| IMRLVGEEGQSIYKL | 141 | Q14164 | |
| GMQEKLARLNLELYG | 211 | Q8IWP9 | |
| KYALMGAAAQLGGIV | 546 | P51798 | |
| GIAYNAKIGGIRMLD | 266 | P29122 | |
| QRVRRFGIMGLYKGL | 256 | O43808 | |
| KRELMYTVELAGGLG | 351 | Q9NZN1 | |
| LQEIMKQTGYLTIGG | 96 | O14733 | |
| YSLRNGEVMGALRKG | 291 | Q8NHB1 | |
| MGVITLESLGKRGYR | 936 | Q32MH5 | |
| MGLGKKGNLVYIIDF | 136 | P48730 | |
| LLKPGGMVLLRDYGR | 281 | Q6P1Q9 | |
| GHLYLLLDMGSGGIK | 561 | Q9P2S2 | |
| LDLKGDLYMAGLAQG | 986 | Q9Y4C0 | |
| DGLILNMAGAKLYDL | 146 | P16050 | |
| AQLGSLKNVMLVLGY | 2461 | Q5S007 | |
| KTLFREGITGLYRGM | 61 | O43772 | |
| MGLKLNGRYISLILA | 1 | Q9NPD7 | |
| GTGLNVRLMLYTRKN | 36 | Q8WWY8 | |
| IRAMTSLYGQLAGLK | 306 | P0C869 | |
| MNGKEVSGRLLYAGR | 251 | Q4VXU2 | |
| GKMRGVLLVLLGLLY | 11 | Q6PEW0 | |
| DQRRGGLRYMGKLVG | 116 | Q9NY56 | |
| YGKSLLELARMENGV | 91 | P49321 | |
| KGGDGIRIYKRNRMI | 86 | Q9NZU5 | |
| NDRGVGMLTRLYNIK | 21 | Q9Y2A7 | |
| LGYEMKDGLRVLNGP | 126 | Q8NB91 | |
| RMQYGLFLKGIGLTL | 306 | P49643 | |
| MGAAGLAGIRIYRID | 361 | Q7RTM1 | |
| MGQIYTGLKSAGRRL | 716 | P49619 | |
| KMIRLITHGLGGEGY | 521 | Q04446 | |
| GKLLYLLDGMLDGQV | 461 | Q969S8 | |
| GAHYDIVGMKRLLQG | 211 | P51878 | |
| IVGMKRLLQGLGYTV | 216 | P51878 | |
| LLGYSKERNMILERG | 1211 | Q9P2K1 | |
| YLDVLGRPMVLAGDK | 426 | P54289 | |
| MLGKEGRLFVLGYAL | 111 | Q5T197 | |
| LHTIVGYGRMKNLLD | 491 | Q9NY28 | |
| MLVRGTEGIKEYINL | 126 | Q96PZ2 | |
| ILTYKQMVGRAGRKG | 471 | O75417 | |
| GMRELGKKLSQYLGN | 1366 | A8TX70 | |
| GKGYMVVLRLATGFS | 121 | Q9BQA9 | |
| MGQIYTGLKSAGRRL | 726 | Q9Y6T7 | |
| YTGRLGQMLVEDIAK | 236 | P36269 | |
| INGYIGNLNELGKMI | 681 | P10911 | |
| MASLGLQLVGYILGL | 1 | P57739 | |
| GSYLLQRGMDSRKIL | 581 | Q76NI1 | |
| LQGLVYLIGNLMGLA | 131 | Q5J8M3 | |
| ETMLKSLLRYQSGGG | 101 | Q6UW02 | |
| GQGLKIIDLQMSDYL | 3411 | Q9P225 | |
| QGKGLMYRGILDALL | 241 | Q3KQZ1 | |
| LYVLRLGQMDTKGLV | 341 | Q92503 | |
| QGLVMRLGIIGGNLY | 366 | O75751 | |
| GLMSLLREMGKGYLA | 461 | P30260 | |
| KIVGMYSDGINVLGL | 201 | P43005 | |
| GDGKLEALYVLMVLG | 41 | A0A087WTH5 | |
| LRLGGTKQDYLMLAT | 46 | Q03701 | |
| ELARTAGYGINILGM | 151 | P02748 | |
| MFGLKRNAVIGLNLY | 1 | Q07820 | |
| EGLNGEISYGIKMIL | 271 | Q9UN75 | |
| LAAVLLKLGGYGMMR | 231 | P03905 | |
| MLLDRSGQGKVYGLI | 1041 | Q8N4C8 | |
| LIGFGLQVAKGMKYL | 1181 | P08581 | |
| MVALAYGLVGAIGLL | 41 | Q8TDU9 | |
| MGKALVDQRELYLGL | 46 | Q9UL33 | |
| AKGYIEVMRLLLQAG | 236 | Q9BZL4 | |
| MYLLLIGAQVLLGIG | 176 | Q9UIG8 | |
| GKNLMFLVLRDGTGY | 141 | O43776 | |
| KGLSDLEIGMYALLG | 911 | Q14C87 | |
| KGLAAGLLYQGLMNG | 71 | Q6PIV7 | |
| LRGKLIYLMGDSTIR | 341 | Q6UWF7 | |
| QGLKIYSGEGEVLLM | 71 | Q6ZV89 | |
| TGLYMLQLAGRGSAV | 2946 | P58107 | |
| TGLYMLQLAGRGSAV | 4011 | P58107 | |
| QATLLMDGRIIFGYK | 246 | Q6UX71 | |
| GQLLRGLSKYGMKNI | 446 | Q96PZ0 | |
| QLLYRMHGEGLTKLT | 361 | O43173 | |
| LGKVGMLNGGRRIDY | 936 | Q9Y6Y8 | |
| REEGAVRGLYKGLSM | 276 | Q86VD7 | |
| EKQMLYLYVLSGIGG | 1086 | P20701 | |
| FELYGDRVLKLGTNM | 246 | Q8WVF1 | |
| NLGIGGAVVVTLYKM | 391 | P22307 | |
| DSNKGMLGLIVYLGM | 201 | Q7L0J3 | |
| LIGGALLNIYTEMGR | 281 | Q96BD0 | |
| GGLYAKLVQRQMLGL | 731 | Q9NP78 | |
| RYLGTLLQVEGMLKT | 176 | Q8N365 | |
| KKGEIGREMYIIQAG | 991 | Q14028 | |
| LYVIRDGSGQMLEIK | 566 | A4UGR9 | |
| MREYKLVVLGSRGVG | 1 | A6NIZ1 | |
| YVLGGGALCMELLTK | 296 | Q8WVN8 | |
| NGLMLLDRSGQGKVY | 1066 | Q9UKE5 | |
| SQQLRMKGDYVLGGL | 26 | Q7RTX0 | |
| LPVGKARQLIGLYTM | 101 | Q9H900 | |
| MKGLYQAAGRILVTL | 1 | A6NML5 | |
| AGLSREYKLVMLGAG | 16 | Q92963 | |
| QYGAAIMLVLGTIGK | 401 | Q9UHI7 | |
| RMIGYGAILVALAGL | 116 | O94956 | |
| LQMLGYLSARGVITG | 246 | A7MD48 | |
| DPSMKILELRYNGGI | 221 | O75635 | |
| GGDLLTYLRKARMAT | 2031 | P08922 | |
| DGLEIRTGQKAYLRM | 166 | P49746 | |
| IVGMLGYCGTVKRNL | 76 | O95859 | |
| VDKGVLGRIGISAMY | 1356 | Q8N9V7 | |
| LRQLAGAMAYLGARG | 226 | Q13470 | |
| MDDAAVLKRRGYLLG | 1 | Q9BXA7 | |
| SVLYMRGRLAEVKGN | 746 | Q9ULT0 | |
| RVMGTLLGLGAVLAY | 56 | P51687 | |
| VKYGMGGLIILFLIA | 2171 | Q92508 | |
| MGGYFIINGIEKVIR | 166 | Q9H9Y6 | |
| RLREMFGLYGQTTGK | 146 | Q9Y6B6 | |
| GLPKRYIIAIMSGLG | 71 | Q8NDX2 | |
| MQRLGAKLGFVSGLI | 166 | Q9Y487 | |
| LLLRTVGMANREKYG | 1176 | Q5THJ4 | |
| FLIYFRLGIKMGKQG | 146 | Q9NR11 | |
| MGLGKKGNLVYIIDF | 136 | P49674 | |
| HGLQMLRTIGVGKYE | 291 | Q96CT2 | |
| AFQYGITDLRGMLKR | 226 | Q00872 | |
| IAFQYGVTDLRGMLK | 336 | Q14896 | |
| YNSKVGGIRMLDGIV | 231 | P29120 | |
| LLMILSLIYVKGRGA | 191 | Q99608 |